tirzepatide real world study
Stop Pretending Prescription Weight Loss Will Evolve by 2026
Tirzepatide, a dual GLP-1/GIP receptor agonist, delivers up to 12% body-weight loss in a year, positioning it as the most potent prescription weight-loss drug available. In trials and real-world studies it also improves glycemic control, offering a two-in-one solution for type 2 diabetes and obesity. Medical Disclaimer: This article